Estrogens and the risk of complex regional pain syndrome (CRPS)

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 1, 2009, Pages 44-52

  de Mos, M ^a   Huygen, F J P M ^a   Stricker, B H Ch ^a   Dieleman, J P ^a   Sturkenboom, M C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Complex regional pain syndrome; Estrogen; Hormones

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BREAST FEEDING; CHILD; CLINICAL ASSESSMENT; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HORMONE RESPONSE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MENSTRUATION; ONSET AGE; ORAL CONTRACEPTION; POPULATION BASED CASE CONTROL STUDY; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; AGED; CASE CONTROL STUDY; ESTROGEN THERAPY; LACTATION; METABOLISM; MIDDLE AGED; NETHERLANDS; SEX DIFFERENCE; TIME;

ADULT; AGE OF ONSET; AGED; CASE-CONTROL STUDIES; COMPLEX REGIONAL PAIN SYNDROMES; CONTRACEPTIVES, ORAL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LACTATION; MENARCHE; MENOPAUSE; MIDDLE AGED; NETHERLANDS; PREGNANCY; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 59049085727     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1683     Document Type: Article

References (44)

1. Harden RN, Bruehl S, Galer BS, et al. Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive? Pain 1999; 83: 211-219.
2. Huygen FJ, de Bruijn AG, Klein J, Zijlstra FJ. Neuroimmune alterations in the complex regional pain syndrome. Eur J Pharmacol 2001; 429: 101-113.
3. Birklein F, Schmelz M. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett 2008; 437: 199-202.
4. Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 1998; 30: 5-11.
5. Leis S, Weber M, Isselmann A, Schmelz M, Birklein F. Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol 2003; 183: 197-204.
6. Tan EC, Oyen WJ, Goris RJ. Leukocytes in complex regional pain syndrome type I. Inflammation 2005; 29: 182-186.
7. Alexander GM, van Rijn MA, van Hilten JJ, Perreault MJ, Schwartzman RJ. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 2005; 116: 213-219.
8. Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijlstra FJ. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm 2002; 11: 47-51.
9. Coderre TJ, Xanthos DN, Francis L, Bennett GJ. Chronic post-ischemia pain (CPIP): a novel animal model of complex regional pain syndrome-type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat. Pain 2004; 112: 94-105.
10. van der Laan L, ter Laak HJ, Gabreels-Festen A, Gabreels F, Goris RJ. Complex regional pain syndrome type I (RSD): pathology of skeletal muscle and peripheral nerve. Neurology 1998; 51: 20-25.
11. de Mos M, de Bruijn AG, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC. The incidence of complex regional pain syndrome: a population-based study. Pain 2007; 129: 12-20.
12. Sandroni P, Benrud-Larson LM, McClelland RL, Low PA. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain 2003; 103: 199-207.
13. de Mos M, Huygen FJPM, Dieleman JP, Koopman JSHA, Stricker BHCh, Sturkenboom MCJM. Medical history and the onset of Complex Regional Pain Syndrome. Pain 2008; 139: 458-466.
14. Ojeda SR. Female reproductive function. In Textbook of Endocrine Physiology (5th edn), Griffin JE, Ojeda SR (eds). Oxford University Press: Oxford, 2004; 186-225.
15. Carr BR, Rehman KS. Fertilization, implantation, and endocrinology of pregnancy. In Textbook of Endocrine Physiology (5th edn), Griffin JE, Ojeda SR (eds). Oxford University Press: Oxford, 2004, 249-273.
16. Frye CA. An overview of oral contraceptives. Neurology 2006; 66: S29-S36.
17. Hickey M, Davis SR, Sturdee DW. Treatment of menopausal symptoms: what shall we do now? Lancet 2005; 366: 409-421.
18. Zhu W, Everson WV, Smart EJ. Estrogen in cardiovascular disease. Curr Opin Lipidol 2004; 15: 589-593.
19. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005; 115: 3318-3325.
20. Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007; 28: 521-574.
21. Bjorling DE, Wang ZY. Estrogen and neuroinflammation. Urology 2001; 57: S40-S46.
22. Murphy E, Steenbergen C. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res 2007; 75: 478-486.
23. Hettne KM, de Mos M, de Bruijn AG, et al. Applied information retrieval and multidisciplinary research: new mechanistic hypotheses in complex regional pain syndrome. J Biomed Discov Collab 2007; 2: 2.
24. Kalaitzidis D, Gilmore TD. Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol Metab 2005; 16: 46-52.
25. Lamberts H, Wood M, Hofmans-Okkes IM. International primary care classifications: the effect of fifteen years of evolution. Fam Pract 1992; 9: 330-339.
26. van der Lei J, Duisterhout JS, Westerhof HP, et al. The introduction of computer-based patient records in the Netherlands. Ann Intern Med 1993; 119: 1036-1041.
27. Schrijvers AJP. Health and Healthcare in the Netherlands. A Critical Self-Assessment of Dutch Experts in Medical and Health Sciences. De Tijdstroom: Utrecht, 1997.
28. de Lusignan S. Codes, classifications, terminologies and nomenclatures: definition, development and application in practice. Inform Prim Care 2005; 13: 65-70.
29. Vlug AE, van der Lei J, Mosseveld BM, et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 1999; 38: 339-344.
30. Schwartzman RJ, Gurusinghe C, Gracely E. Prevalence of complex regional pain syndrome in a cohort of multiple sclerosis patients. Pain Physician 2008; 11: 133-136.
31. Merlino LA, Cerhan JR, Criswell LA, Mikuls TR, Saag KG. Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women. Semin Arthritis Rheum 2003; 33: 72-82.
32. Pope JE, Bellamy N, Stevens A. The lack of associations between rheumatoid arthritis and both nulliparity and infertility. Semin Arthritis Rheum 1999; 28: 342-350.
33. Karlson EW, Mandl LA, Hankinson SE, Grodstein F. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum 2004; 50: 3458-3467.
34. Alonso A, Jick SS, Olek MJ, Ascherio A, Jick H, Hernan MA. Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 2005; 62: 1362-1365.
35. Pladevall-Vila M, Delclos GL, Varas C, Guyer H, Brugues-Tarradellas J, Anglada-Arisa A. Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity. Am J Epidemiol 1996; 144: 1-14.
36. Hernan MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000; 55: 848-854.
37. Thorogood M, Hannaford PC. The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 1998; 105: 1296-1299.
38. Walitt B, Pettinger M, Weinstein A, et al. Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials. Arthritis Rheum 2008; 59: 302-310.
39. Iijima T, Tada H, Hidaka Y, et al. Prediction of postpartum onset of rheumatoid arthritis. Ann Rheum Dis 1998; 57: 460-463.
40. Lansink M, de Boer A, Dijkmans BA, Vandenbroucke JP, Hazes JM. The onset of rheumatoid arthritis in relation to pregnancy and childbirth. Clin Exp Rheumatol 1993; 11: 171-174.
41. Gayed M, Gordon C. Pregnancy and rheumatic diseases. Rheumatology (Oxford) 2007; 46: 1634-1640.
42. Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann NY Acad Sci 1998; 840: 45-50.
43. Bruehl S, Harden RN, Galer BS, et al. External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain 1999; 81: 147-154.
44. Harden RN, Bruehl S. Diagnostic criteria: the statistical derivation of the four criterion factors. In CRPS: Current Diagnosis and Therapy, Wilson PR, Stanton-Hicks M, Harden RN (eds). IASP Press: Seattle, 2005, 45-58.